US3966908A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating degenerative joint afflictions
Assignee: Lescarden Ltd
•
Filing: 1975-07-10
•
Granted: 1976-06-29
•
Expires: 1995-07-10
Abstract
Abstract A method for treating degenerative afflictions of the joints is described which comprises administering to a mammal suffering from a degenerative joint affliction an effective amount of a produce derived from granulated animal cartilage.
Inventors
- 👤 Leslie L. Balassa
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 18:52
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/32
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
103 words
A method of treating degenerative joint afflictions to obtain a protracted symptomatic remission period, the alleviation of pain and the promotion of increased joint mobility in a human suffering from said degenerative joint affliction which comprises subcutaneously administering to said human in a distensible area of the body and in a plurality of individual treatments a total dose of between about 150 and 1,000 cc consisting essentially of a liquid extract of essentially pure granulated cartilage material, substantially free from adhering tissue, and subcutaneously administering to said human at least about 10 cc of said liquid extract in each of said individual treatments.
Claim 2
Independent Claim
103 words
A method of treating degenerative joint afflictions to obtain a protracted symptomatic remission period, the alleviation of pain and the promotion of increased joint mobility in a human suffering from said degenerative joint affliction which comprises subcutaneously administering to said human in a distensible area of the body and in a plurality of individual treatments a total dose of between about 150 and 1,000 cc consisting essentially of a liquid extract of essentially pure granulated cartilage material, substantially free from adhering tissue, and subcutaneously administering to said human at least about 10 cc of said liquid extract in each of said individual treatments.
Claim 3
Dependent Claim
39 words
The method of claim 1 wherein each of said individual treatments comprises forming at least one subcutaneous depot in a distensible area of the body containing from about 10 cc to about 50 cc of said liquid cartilage extract.
Claim 4
Dependent Claim
25 words
The method of claim 2 which comprises administering said total dose at predetermined intervals over a period of from about 3 to about 8 weeks.
Claim 5
Dependent Claim
20 words
The method of claim 2 wherein each of said subcutaneous depots contains about 25 cc of said liquid cartilage extract.
References Cited (Backward Citations)
US3318774A
Cited
US3400199A
Cited
US3476855A
Cited
US3478146A
Cited
US3458397A
Cited
US3551560A
Cited
US3703575A
Cited
US3772432A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-06-29 | 1979-12-29 | 1980-06-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-06-29 | 1983-12-29 | 1984-06-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-06-29 | 1987-12-29 | 1988-06-29 | $7700.00 | Window Closed / Lapsed |